Navigation Links
Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
Date:6/3/2008

ly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.

Safe Harbor Statement

This press release contains forward-looking statements including without limitation statements related to the future development and timing of late-stage trials of voreloxin (formerly SNS-595) and potential safety and efficacy and commercial potential of voreloxin. Words such as "promising," "advance," "look forward," "expects" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Sunesis' current expectations. Forward-looking statements involve risks and uncertainties. Sunesis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the risk that Sunesis' drug development activities or those of its partners, including enrollment and reporting of results, could be halted significantly or delayed for various reasons; the risk that Sunesis' clinical trials for voreloxin or its other programs may not demonstrate safety or efficacy or lead to regulatory approval; the risk that preliminary data and trends may not be predictive of future data or results; the risk that Sunesis' preclinical studies and clinical trials may not satisfy the requirements of the FDA or other regulatory agencies; risks related to the conduct of Sunesis' clinical trials and manufacturing; and risks related to Sunesis' need for additional funding. These and other risk factors are discussed under "Risk Factors" and elsewhere in Sunesis' Annual Report on Form 10-K for the year ended December 31, 2007, Sunesis' Quarterly Report on Fo
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
2. Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
3. Sunesis Pharmaceuticals to Report Third Quarter 2007 Financial Results
4. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
5. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
6. Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Womens Cancer
7. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
8. Sunesis Pharmaceuticals to Report Financial Results for the First Quarter on May 8, 2008
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... NCERC at Southern Illinois University ... findings on corn stover pretreatment methods at a ... Washington, D.C. , “Arun’s selection for presentation ... testament to the success of our postdoctoral fellowship ... the foresight and vision of SIUE and the ...
(Date:7/30/2014)... 30, 2014 Immunology Summit-2014 ... Immunologists, Principle Investigators, scientists in the field, which ... Professor at Case Western Reserve University School of ... address on “The effects of recombinant human ... matrix metalloproteinase-9”. Arya Biragyn, a Senior investigator at ...
(Date:7/29/2014)... hurdled a number of significant technological challenges in ... technology originally created for the James Webb Space ... Harvey Moseley, a scientist at NASA,s Goddard Space ... electrostatically actuated microshutter arrays that is, those ... as functional as the current technology,s magnetically activated ...
(Date:7/29/2014)... be separated from its properties? On July 29, the ... of the first Cheshire Cat experiment, separating a neutron ... Orange, CA, and Vienna University of Technology. , Chesire ... thought Alice in Wonderland, "but a grin without a ... in my life!" Alice,s surprise stems from her experience ...
Breaking Biology Technology:NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 2NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 3Unveiling Breakthroughs in Clinical & Cellular Immunology 2Unveiling Breakthroughs in Clinical & Cellular Immunology 3Revolutionary microshutter technology hurdles significant challenges 2Revolutionary microshutter technology hurdles significant challenges 3Revolutionary microshutter technology hurdles significant challenges 4The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4
... 2011 Zacharon Pharmaceuticals, Inc. today announced that ... collaboration with Pfizer Inc. to develop drugs for ... value of the collaboration to Zacharon is approximately ... development of compounds that may be discovered using ...
... as well as students working in micro-electromechanical systems ... developing common MEMS fabrication processes. A fundamental, comprehensive ... to be an important game-changing asset for the ... Handbook is an exhaustive design reference for researchers ...
... and DANVILLE, Pa., April 6, 2011 Definiens, the ... life sciences firm specializing in advanced cancer diagnostics, today ... tool for the diagnosis of cancer. Cernostics will apply ... tests for the treatment of a variety ...
Cached Biology Technology:Zacharon Pharmaceuticals Announces Research and Development Collaboration With Pfizer to Develop Drugs for Multiple Rare Disorders 2Zacharon Pharmaceuticals Announces Research and Development Collaboration With Pfizer to Develop Drugs for Multiple Rare Disorders 3MEMS Materials and Processes Handbook -- a comprehensive, practical resource 2Definiens and Cernostics Partner to Develop Multiplexed Cancer Diagnostic Tests 2Definiens and Cernostics Partner to Develop Multiplexed Cancer Diagnostic Tests 3
(Date:7/30/2014)... JOSE, Calif. , July 30, 2014 /PRNewswire/ ... partnership with the United States Air Force Research ... proposed by Binghamton University ... human performance monitoring (HPM). The $425,000 project, with ... electronics packaging firm i3 Electronics, Inc. ( ...
(Date:7/29/2014)... the University of Bristol,s Nutrition and Behaviour Unit (NBU) ... account when planning meals. , The research, to be ... Behavior Conference (SSIB 2014) in Seattle, USA this week ... , The team was led by Professor Jeff Brunstrom, ... , As part of a Biotechnology and Biological Sciences ...
(Date:7/29/2014)... of science, researchers sometimes need to get back ... just that to study the impacts of the ... reef ecosystems at two remote locations in the ... tracking and computer simulation, McCauley, an assistant professor ... Biology, and his colleagues sought to understand whether ...
Breaking Biology News(10 mins):Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms 2Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms 3Underwater elephants 2Underwater elephants 3
... of food poisoning from the food chain is the aim ... Research Council (BBSRC) and the world-leading UK-based poultry breeding company ... cases of food poisoning a year in England and Wales ... 600 million a year. It is usually passed to humans ...
... Feb. 15, 2012 /PRNewswire-iReach/ -- The ... Groupware Collaborative, announced a new round of speakers and ... Forum , part of HIMSS12 on February 23, 2012 ... exhibition from the Healthcare Information and Management Systems Society ...
... airborne laser technology, satellite mapping, and ground-based plot surveys, ... high-resolution estimates of carbon stocks in remote and fragile ... to map carbon stocks in rugged geographic regions and ... employed to support conservation and climate-change mitigation under the ...
Cached Biology News:New research to help eliminate most common food poisoning bug 2Collaborative Health Consortium Announces eCollaboration Forum Final Agenda for HIMSS 2012 2Collaborative Health Consortium Announces eCollaboration Forum Final Agenda for HIMSS 2012 3 Super high-resolution carbon estimates for endangered Madagascar 2